CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer TreatmentDavid A. Flockhart, Suzanne Lemler, Richard M. Weinshilboum et al.|JNCI Journal of the National Cancer Institute|2005Cited by 947
Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast CancerN. Lynn Henry, Anna Maria Storniolo, Faouzi Azzouz et al.|Journal of Clinical Oncology|2012Cited by 391
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitorsN. Lynn Henry, Daniel J. Clauw, Jon T. Giles et al.|Breast Cancer Research and Treatment|2007Cited by 238
Estrogen Receptor Genotypes Influence Hot Flash Prevalence and Composite Score Before and After Tamoxifen TherapyYan Jin, Vered Stearns, Daniel F. Hayes et al.|Journal of Clinical Oncology|2008Cited by 61
Modeling hot flushes and quality of life in breast cancer survivorsKevin L. Rand, Janet S. Carpenter, Julie L. Otte et al.|Climacteric|2010Cited by 54